Publications by authors named "Emily Hsu"

Claim this Profile
P
Persistent Activation of Endothelial Cells is Linked to Thrombosis and Inflammation in Cerebral Cavernous Malformation Disease.
Helios Gallego-Gutierrez, Eduardo Frias-Anaya, Cassandra Bui, Louie Zhao, Emily Hsu

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and transcriptomic landscape of HER2-low breast cancer.
Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos, Emily Hsu

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intersectional Approach to Cervical Cancer Screening Disparities by Race/Ethnicity and Immigrant Status.
Jane J Chen, Indra N Sarkar, Emily Hsu, Don S Dizon

J Womens Health (Larchmt)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant.
Scott Thomas, Elysia Roche, Pujan Desai, Nela Pawlowska, Diana Bauer, Emily Hsu

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer.
Emily Hsu, Sabrina M Arezo, Stephanie L Graff

Curr Treat Options Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters.
Emily Hsu, Katherine Hutchison, Yao Liu, Charles M Nicolet, Shannon Schreiner

Nucleic Acids Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus E1A binding to DCAF10 targets proteasomal degradation of RUVBL1/2 AAA+ ATPases required for quaternary assembly of multiprotein machines, innate immunity, and responses to metabolic stress.
Nathan R Zemke, Emily Hsu, William D Barshop, Jihui Sha, James A Wohlschlegel

J Virol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models.
Scott Thomas, Elysia Roche, Pujan Desai, Nela Pawlowska, Diana Bauer, Emily Hsu

Res Sq· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih-Yuan Hsu, Emily Hsu

JAMA Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Paul M Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Emily Hsu

Future Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.
Jennifer A Woyach, Paul M Barr, Thomas J Kipps, Jacqueline C Barrientos, Inhye E Ahn, Emily Hsu

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Current Landscape, Attitudes, and Perceived Barriers of Virtual Medicine in Underserved Populations.
Jasmin Hundal, Katarina Bade, Emily Hsu, Jyoti Chhabra, Alvaro Menendez

JCO Oncol Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Carol Moreno, Richard Greil, Fatih Demirkan, Alessandra Tedeschi, Bertrand Anz, Emily Hsu

Haematologica· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.
Jan A Burger, Tadeusz Robak, Fatih Demirkan, Osnat Bairey, Carol Moreno, Emily Hsu

Leuk Lymphoma· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.
Paul M Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Emily Hsu

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated Mycobacterium abscessus Infection in a Burn Patient.
Emily H Hsu, Sierra Young, Nicola Clayton, Jin Lee, Naomi Hauser

J Burn Care Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone.
Emily Hsu, Omar Eton, Akshay V Patel, Richard Cartun, Jonathan S Earle

J Drugs Dermatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition.
Emily Hsu, Nathan R Zemke, Arnold J Berk

Elife· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer.
Tamas A Gonda, Jarwei Fang, Martha Salas, Catherine Do, Emily Hsu

Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, Yu Shyr, Samuel M Rubinstein, Chih-Yuan Hsu, Emily Hsu

Lancet· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epilepsy and EEG Phenotype of SLC13A5 Citrate Transporter Disorder.
Qian-Zhou Yang, Emily M Spelbrink, Kimberly L Nye, Emily R Hsu, Brenda E Porter

Child Neurol Open· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NMDA receptors in the basolateral amygdala mediate acquisition and extinction of an amphetamine conditioned place preference.
Jarid Goodman, Emily Hsu, Mark G Packard

Behav Neurosci· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Carol Moreno, Richard Greil, Fatih Demirkan, Alessandra Tedeschi, Bertrand Anz, Emily Hsu

Lancet Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Jacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, Neil E Kay, Nishitha M Reddy, Emily Hsu

Clin Lymphoma Myeloma Leuk· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Granulocytic Sarcoma or Extramedullary Acute Myelomonocytic Leukemia of the Gallbladder.
Erik A Holzwanger, Zainab Alam, Emily Hsu, Andrew Hsu, Mark Mangano

Am J Case Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis